SEC Form 4 · accession 0001209191-15-026165
PharMerica CORP · PMC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Berard Tomassetti
Officer — SVP and CAO
Period of report
Mar 11, 2015
Accepted (ET)
Mar 13, 2015 · 5:47 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001388195
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $.01 par value | Mar 11, 2015 | F | 304 | $26.22 | D | 7,486 | D | |
| Common Stock, $.01 par valueF1 | Mar 12, 2015 | S | 3,344 | $26.4426 | D | 4,142 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents the weighted average purchase price for the transactions reported on this line. The range of prices for the transactions reported on this line was $26.4350 to $26.4850, inclusive. The reporting person will provide to the Commission, the issuer and any stockholder, upon request, full information regarding the number of shares purchased or sold at each separate price.